Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Piyong Sola, Praveen Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S.S Pindiprolu & Mamta Kumari. (2020) Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery 17:8, pages 1119-1132.
Read now
Read now
Omidreza Jafarieh, Shadab Md, Mushir Ali, Sanjula Baboota, J. K. Sahni, Bhavna Kumari, Aseem Bhatnagar & Javed Ali. (2015) Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Development and Industrial Pharmacy 41:10, pages 1674-1681.
Read now
Read now
Shadab Md, Shadabul Haque, Mohammad Fazil, Manish Kumar, Sanjula Baboota, Jasjeet K Sahni & Javed Ali. (2014) Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method. Expert Opinion on Drug Delivery 11:6, pages 827-842.
Read now
Read now
Articles from other publishers (22)
Shalu Singh & Rahul Shukla. (2023) Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease. AAPS PharmSciTech 24:7.
Crossref
Crossref
Bharat Tukaram Agiwale, Abhish Bhagwan Jadhav, Sanjay Jayprakash Kshirsagar, Mrudula Hemant Bele, Chetan Ramrao Sonawane, Smita Prakash Kakad & Sapana Prabhakar Ahirrao. (2023) Liposomal Drug Delivery System as an Emerging Technique for Treatment
of “Neurodegenerative Diseases”. Current Nanomedicine 13:1, pages 17-26.
Crossref
Crossref
Saad Alkahtani, Norah S. AL-Johani & Saud Alarifi. (2023) Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects. International Journal of Molecular Sciences 24:2, pages 1340.
Crossref
Crossref
Mohammed Tahir Ansari, Dipti Srivastava, Deviga Kaliyappan, Wai Hau Tung, Farheen Sami, Abdullah Khan & Md Saquib Hasnain. 2022. Systems of Nanovesicular Drug Delivery. Systems of Nanovesicular Drug Delivery
387
401
.
Manpreet Kaur, Rupinder Kaur Sodhi, Vaskuri G.S. Sainaga Jyothi, Veerabomma Haritha Sree, Shubhra, Pankaj Kumar Singh, Neelesh Kumar Mehra, Dharmendra Kumar Khatri, Saurabh Srivastava, Shashi Bala Singh, Jitender Madan & Satish Sardana. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
289
345
.
Li-Ming Shen, Meng-Chu Li, Wen-Juan Wei, Xin Guan & Jing Liu. (2021)
In Vitro
Neuroprotective Effects of Macrophage Membrane-Derived Curcumin-Loaded Carriers against 1-Methyl-4-phenylpyridinium-Induced Neuronal Damage
. ACS Omega 6:47, pages 32133-32141.
Crossref
Crossref
Danielle Paige Anthony, Manasa Hegde, Shreya S. Shetty, Thasneema Rafic, Srinivas Mutalik & B.S. Satish Rao. (2021) Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases. Life Sciences 274, pages 119326.
Crossref
Crossref
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Salman Ul Islam, Adeeb Shehzad, Muhammad Bilal Ahmed & Young Sup Lee. (2020) Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders. Molecules 25:8, pages 1929.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
89
101
.
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
75
88
.
K. Hannink, L. ter Brake, N.G.M. Oonk, A.A. Wertenbroek, M. Piek, L. Vree-Egberts, M.J. Faber, J. van der Palen & L.D. Dorresteijn. (2019) A randomized controlled efficacy study of the Medido medication dispenser in Parkinson’s disease. BMC Geriatrics 19:1.
Crossref
Crossref
Angeline Tzeyung, Shadab Md, Subrat Bhattamisra, Thiagarajan Madheswaran, Nabil Alhakamy, Hibah Aldawsari & Ammu Radhakrishnan. (2019) Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery. Pharmaceutics 11:1, pages 26.
Crossref
Crossref
You Jung Kang, Eric Gerard Cutler & Hansang Cho. (2018) Therapeutic nanoplatforms and delivery strategies for neurological disorders. Nano Convergence 5:1.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
Meltem Çetin, Eren Aytekin, Burçin Yavuz & Sibel Bozdağ-Pehlivan. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors
117
147
.
A. H. Heald, M. Livingston, M. Stedman & Z. Wyrko. (2016) Higher levels of apomorphine and rotigotine prescribing reduce overall secondary healthcare costs in Parkinson's disease. International Journal of Clinical Practice 70:11, pages 907-915.
Crossref
Crossref
Florent F. Richy, Guilhem Pietri, Kimberly A. Moran, Emmanuelle Senior & Lydia E. Makaroff. (2013) Compliance with Pharmacotherapy and Direct Healthcare Costs in Patients with Parkinson’s Disease: A Retrospective Claims Database Analysis. Applied Health Economics and Health Policy 11:4, pages 395-406.
Crossref
Crossref
P. Colombo, S. Cagnani, F. Buttini, P. Santi, F. Sonvico, P. Russo & G. Colombo. 2013. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Mariacristina GagliardiGiuseppe Bardi & Angelo Bifone. (2012) Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS. Therapeutic Delivery 3:7, pages 875-887.
Crossref
Crossref
Javed Ali, Shadab Md, Sanjula Baboota & Jasjeet K. Sahni. 2012. Patenting Nanomedicines. Patenting Nanomedicines
99
149
.
Carlos Spuch & Carmen Navarro. (2011) Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease). Journal of Drug Delivery 2011, pages 1-12.
Crossref
Crossref